E-mail:BD@ebraincase.com
Tel:+8618971215294
English 中文版
Virus Vector - Viral Vector Production - BrainCaseVirus Vector - Viral Vector Production - BrainCase
  • Home
  • Virus product library
    CRISPRRNAiHSV-helperRV-helperNeurophilic virusCalcium SensorsOptogenetics activationOptogenetics inhibitionChemical geneticsSparse labelingFluorescent proteinBiosensorsRecombinaseApoptosis & AutophagyDisease ModelNeurotoxicityOther
  • Products & Service

    Product Center

    Virus

    VSV-circuit research-vaccine and gene therapy research-BrainCase
    Retrovirus-RCAS-TVA-BrainCase
    Lentivirus Vector - Lentivirus Production - BrainCase
    Rabies Virus Vector - RBV Vector - BrainCase
    Herpes simplex virus-Oncolytic and anterograde tracing-Brain Case
    PRV-retrograd multisynaptic-Peripheral-Btain Case
    AAV-gene therapy vectors-BrainCase

    Animal Model

    Neurological Disease Models-BrainCase
    Tumor animal models-anti-tumor-BrainCase
    Digestive System Disease Animal Model-Brain Case
    Cardiovascular System Disease Animal Models-Brain Case

    Plasmid Construction

    Library Construction
    Plasmid design and construction

    Popular Applications

    Gene Regulation

    Gene Overexpression-Brain Case
    RNA interference(RNAi)-siRNA-Brain Case
    Gene Editing - CRSIPR cloning - BrainCase

    Neural Circuit Function Research

    Optogenetics - BrainCase
    Chemical genetics-DREADDs-Brain Case
    Calcium signal recording-Gels- Brain Case
    GRAB Neurotransmitter Fluorescent Probe- Brain Case
    Functional Magnetic Resonance Imaging Technology- Brain Case

    Research on the structure of neural circuits

    Direct Input and Output-viral vectors- Brain Case
    Anterograde Mono-synaptic Tracing -HSV- Brain Case
    Antrograde Muti-synaptic Tracing-HSV & VSV-Brain Case
    Retrograde Mono-synaptic Tracing-Rabies Virus-Brain Case
    Retrograde Muti-synaptic Tracing-PRV-Brain Case

    Featured Services

    Nervous System Disease Drug Effect

    Alzheimer's disease-AD-Brain Case
    Depression-mental disorders-Brain Case
    Parkinson's disease--PD-Brain Case
    Epilepsy-an ancient neurological disorder-Brain Case

    AAV Serotype Screening

    AAV Serotypes screening-gene therapy-Brain Case

    Tumorigenicity Test

    Tumorigenicity Testing-Evaluation of tumor models-Brain Case

    Efficacy of Oncolytic Virus

    Oncolytic virus-for cancer therapy-Brain Case
    Herpes Virus Vector-anti-tumor- BrainCase
    Vesicular stomatitis virus-killing tumor cells-Brain Case
  • News
    Corporate News New Product Launch Media Activity Investor News
  • Support
    Literature interpretation Customer article Video Zone FAQs
  • About Us
  • Contact
    Contact UsJoin us
  • 中文
    English 中文版
  • Home
  • Support
  • Customer article
  • Support
  • Literature interpretation
  • Customer article
  • Video Zone
  • FAQs

Customer Article|Targeting vulnerable microcircuits in the ventral hippocampus of male transgenic mice to rescue Alzheimer‑like social memory loss

Release time:2024-10-15 17:21:14

In Alzheimer's disease (AD) patients, the hippocampus is one of the first regions to be affected. Episodic memory loss is a prominent clinical feature of AD and is closely associated with tau pathology and hippocampal damage. But how do different hippocampal neurons respond to tau accumulation, and what roles do they play in AD-like social memory loss? This study elucidates distinct protein and phosphorylation networks between dCA1 and vCA1, highlighting the susceptibility of vCA1 microcircuits to AD-like tau accumulation.

The ventral hippocampus is vulnerable to AD‑like tau pathology

In 6-month-old male 3xTg-AD mice, a significant number of AT8-ir neurons were observed in the vCA1 region, but not in the dCA1. Similarly, in 3-month-old male and female P301L mice expressing the longest hTau isoform and the FTDP-17 P301L mutation, hyperphosphorylated tau significantly accumulated in the cell bodies and neuronal processes of the ventral hippocampus, particularly in the vCA1 region. These data suggest that the vCA1 is more sensitive to AD-like tau pathology than the dCA1.

To further investigate the differences between the vCA1 and dCA1 under physiological conditions and in the presence of AD-like tau pathology, researchers performed proteomic and phosphoproteomic analyses in WT and P301L mice. They found 158 differentially expressed proteins between the vCA1 and dCA1 in WT mice, indicating distinct protein networks along the anterior-posterior axis of the hippocampal CA1 region under physiological conditions. Compared to WT mice, P301L mice had 50 and 45 differentially expressed proteins in the vCA1 and dCA1, respectively. In the vCA1, the top 30 differentially expressed proteins between WT and P301L mice were different from those in the dCA1.

Subsequently, they conducted phosphoproteomic analysis to delineate the distinct phosphoprotein networks in the two groups. Compared to the dCA1, the vCA1 in WT and P301L mice showed modifications in 644 and 505 proteins and 1021 and 839 sites, respectively (For details, see the original text in Supplementary File 1: Fig. S6). In the vCA1 of P301L mice, the phosphorylation levels of tau at T181 and S191 (tau-T181 and tau-S191) and CaMKIIa at S272 (CaMKIIa-S272) were significantly higher than in the vCA1 of WT mice (Fig. 1d). However, the phosphorylation level of neuronal navigator 1 at S197 (NAV1-S197) was lower in the vCA1 of P301L mice than in WT mice (Fig. 1d). These data indicate that the distribution of AD-like tau pathology-related protein and phosphoprotein networks differs along the anterior-posterior axis of the hippocampal CA1 region.TauvCA1 accumulation impairs social memory.

Fig. 1 Proteomics and phosphoproteomics of dorsal hippocampal CA1 (dCA1) and ventral hippocampal CA1 (vCA1) in P301L mice.

TauvCA1 accumulation impairs social memory

Researchers conducted social exploration and memory tests on 6-month-old 3xTg-AD mice that showed significant p-Tau accumulation in the vCA1. During exploration, both nTg and 3xTg-AD mice spent more time on the side with a new mouse than on the side with an empty cup, indicating a preference for social approach (P < 0.01). Notably, nTg mice showed a significant preference for the new stimulus in the social memory test (P < 0.01), while this preference was not observed in 3xTg-AD mice.

Subsequently, researchers performed social exploration and memory tests on 3-month-old male P301L mice, which accumulated hyperphosphorylated tau in the vCA1 but not in the dCA1. In the social tests, both WT and P301L mice showed a strong preference for social approach (P < 0.01), but P301L mice spent equal time interacting with familiar and new individuals (P > 0.05) and had lower social recognition scores (P < 0.01). These findings suggest that pathological tau accumulation in the vCA1 is associated with social memory deficits in AD mice.

Fig. 2 Tau accumulation in vCA1 impairs social memory, For more details, see the original figures in the supplementary material of the text.

Overexpression of hTau in excitatory neurons impairs recognition of familiar conspecifics. Overexpression of hTau in PV neurons impairs identification of novel conspecifics

To investigate which types of hippocampal neurons are sensitive to the accumulation of pathological tau and responsible for tau-induced social memory deficits, researchers performed double immunostaining on brain slices from nTg and 3xTg-AD mice containing the vCA1 subregion. Compared to nTg mice, more AT8 and pT205 signals were colocalized with CaMKII (a marker of excitatory neurons) and PV (a marker of PV neurons), respectively. Quantitative analysis of 6-month-old 3xTg-AD mice showed that 84% of AT8+ signals were located within CaMKII neurons, and 92% of PV neurons were pT205-ir. These data indicate that both excitatory and PV neurons in the vCA1 are prone to AD-like tau accumulation.

Fig. 3 Overexpression of hTau in excitatory and PV neurons impairs social memory

Tau accumulation impairs discrimination‑associated firing of excitatory and PV neurons in the vCA1

The researchers assessed the changes in excitability of excitatory and PV neurons in the vCA1 after overexpressing hTau using in vitro patch-clamp recordings. They also analyzed the real-time activity of excitatory and PV neurons in the vCA1 during social recognition via in vivo calcium imaging recordings. Given that PV neurons inhibit local excitatory neurons through the neurotransmitter GABA, the researchers further investigated the changes in GABA release to excitatory neurons in vCA1-hTauPV mice and its contribution to social memory deficits. They used AAV-CaMKII-iGABASnFR (a genetically encoded GABA sensor obtained from Brain Case Biotech) to target excitatory neurons in the vCA1 and monitored real-time GABA signals in vCA1-hTauPV mice throughout the social memory test. They found that hTau accumulation inhibits and disrupts the discharge of excitatory and PV neurons in the vCA1. The accumulation of hTau in excitatory neurons impairs social memory by suppressing the discharge of excitatory neurons associated with familiar conspecific recognition. In contrast, hTau accumulation in PV neurons leads to the misidentification of a novel identical familiar feature due to the lack of inhibition in the excitatory neurons of the vCA1.

Fig. 4 vCA1-hTauPV accumulation disinhibits excitatory neurons during novel conspecific identification

Photoactivation of excitatory and PV neurons in the vCA1 rescues hTau accumulation‑impaired social memory

Using genetically encoded optogenetic tools to activate excitatory neurons and PV neurons in the vCA1 region significantly increased the interaction time and recognition scores with novel conspecifics in mice. This indicates that optogenetic activation of excitatory neurons and PV neurons can alleviate and correct social memory deficits caused by hTau accumulation.

Fig. 5 Photoactivation of excitatory and PV neurons rescues tau accumulation-impaired discrimination in social memory.

UA reduces pathological tau load and rescues tau‑impaired social memory

At specific concentrations, the natural triterpenoid compound ursolic acid (UA) significantly reduced total Tau (tau5, HT7) and phosphorylated Tau (p-Tau; AT8) levels in primary neurons and HEK293 cells expressing full-length hTau. In vivo, vCA1-hTau mice treated with low-dose UA [15 mg/(kg·d)] exhibited a significant decrease in total Tau, hTau, and p-Tau levels (P < 0.05 or P < 0.01; Additional file 1: Fig. S26a). This treatment also improved social memory, as evidenced by increased exploration of novel mice and higher recognition scores (P < 0.01; Additional file 1: Fig. S26b, c). No adverse effects were observed in C57BL/6 mice treated with low-dose UA (P > 0.05; Additional file 1: Fig. S27). UA treatment promoted autophagy by enhancing the translocation of TFEB from the cytoplasm to the nucleus (Fig. 6b), increased LC3B-II levels, and decreased p62 levels in HEK293-hTau cells. The beneficial effects of UA on tau reduction, enhanced autophagy, recovery of neuronal excitability, and improvement in social memory were abolished by knocking down TFEB using AAV-hSyn-shTFEB (P < 0.01; Fig. 6e-j, Additional file 1: Fig. S28). Therefore, UA can rescue social memory deficits caused by tau accumulation through TFEB-dependent autophagy enhancement, potentially offering a promising strategy for preventing AD.

Fig. 6 Ursolic acid (UA) reduces the pathological tau load to improve social memory via TFEB(For details on the results of downregulating TFEB protein expression induced by UA, see the original images in Figure 7 e-j of the text)

In this article, the researchers investigated the changes in GABA release to excitatory neurons in vCA1-hTauPV mice and its contribution to social memory deficits. They used our company's genetically encoded GABA sensor “BC-0341 AAV-CaMKII-iGABASnFR.”
If you are interested in the application of this product, please feel free to contact us at bd@braincase.cn.

Fig. 7 Schematic of GABA signal recording in the social memory test. Detection of GABA neurotransmitter signaling.

Brain Case Biotech provided various serotypes of AAV viruses used in this study. If interested, please contact us at BD@ebraincase.com


💥Holiday

Special

Offers

Click to fill in the requirements and submit them to us!

Service Type :

Select the service you'd like to purchase.

Order Information(Premade-AAVs)

Please provide us some information about the service you'd like to order.

Detailed requirements:

scroll

Order Information(Custom AAV/Lentivirus)

Please provide us some information about the service you'd like to order.

Gene ID or gene information:

Selection of the reporting gene:

Special Instructions:

scroll

Order Information(Others)

Please provide us some information about the service you'd like to order.

Virus name/Detailed requirements:

scroll

Related products

Client Article | Cell Metabolism | Liu Danqian’s Team at the Institute of Neuroscience, CAS, Decodes the Oxidation-Sleep Code in Substantia Nigra Neurons

Client Article | Cell Metabolism | Liu Danqian’s Team at the Institute of Neuroscience, CAS, Decodes the Oxidation-Sleep Code in Substantia Nigra Neurons

Client Publication | Nature Communications | USTC Team Led by Zhi Zhang, Juan Li, and Peng Cao Unveils Neural Circuit Mechanism of Male-Specific Conditioned Pain Hypersensitivity

Client Publication | Nature Communications | USTC Team Led by Zhi Zhang, Juan Li, and Peng Cao Unveils Neural Circuit Mechanism of Male-Specific Conditioned Pain Hypersensitivity

Customer Publication | Sci Adv | Team of Zhong Chen & Yi Wang from Zhejiang Chinese Medical University Reveals Astrocyte-Mediated Mechanism in Fear Extinction

Customer Publication | Sci Adv | Team of Zhong Chen & Yi Wang from Zhejiang Chinese Medical University Reveals Astrocyte-Mediated Mechanism in Fear Extinction

Client Article | Cell Stem Cell Teams Led by Jun Qin, Qi Han, Moubin Lin, and Xiao Su Reveal How Chronic Stress Induces Intestinal Stem Cell Aging via the Vagus Nerve–Cholinergic Pathway

Client Article | Cell Stem Cell Teams Led by Jun Qin, Qi Han, Moubin Lin, and Xiao Su Reveal How Chronic Stress Induces Intestinal Stem Cell Aging via the Vagus Nerve–Cholinergic Pathway

map
{dede:global.cfg_webname/}

Virus product library

CRISPR
RNAi
Neurophilic virus
Optogenetics activation
Biosensors

News

Corporate News
New Product Launch
Media Activity
Investor News

Support

Literature interpretation
Customer article
Video Zone
FAQs
微信

WhatsApp Business Account

Tel: +8618971215294
E-mail: BD@ebraincase.com

Address:-

Address:-

  • Copyright © 2024 Brain Case All Rights Reserved.